| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_989ecca69fc47fadd546bf9a0db59629 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E21B43-267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-72 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K8-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E21B43-267 |
| filingDate |
2013-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90832b6688151babb9712fa5f25df70c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fad66b70799f06e81c6858578d30cef2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f229084a1e620927632430d7a55958b |
| publicationDate |
2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015038153-A1 |
| titleOfInvention |
Conductivity enhancenment of complex fracture networks in subterranean formations |
| abstract |
Some embodiments provide a method comprising a) introducing a delayed-release acid and a gelling agent into a subterranean formation at a rate and pressure sufficient to create or enhance at least one fracture in a first treatment interval; b) contacting the delayed-release acid with a face of the fracture in the first treatment interval so as to etch one or more channels thereon; c) introducing a combination of non-degradable and degradable micro-proppant particulates into the subterranean formation so as to place them into the fracture in the first treatment interval, wherein they at least partially inhibit fluid flow therethrough; d) introducing a combination of non-degradable and degradable proppant particulates into the subterranean formation so as to place them into the fracture in the first treatment interval, wherein they at least partially inhibit fluid flow therethrough; e) repeating (a) through (d) at a second treatment interval. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10920132-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11008506-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10214682-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9938810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10895140-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020076993-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11505737-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11156070-B2 |
| priorityDate |
2013-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |